Published in Cardiovascular Device Liability Week, June 17th, 2007
In the position, Dr. Gambhir will oversee the next phases of MIVT's research and human clinical studies in India as the Company steps up development and commercialization of its novel, biocompatible cardiovascular stents. Dr. Gambhir has been an...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cardiovascular Device Liability Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.